Klonopin is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Mckesson Rxpak Inc. The primary component is Clonazepam.
| Product ID | 65084-308_6d30aea8-0971-438f-b1eb-bdd067d23165 |
| NDC | 65084-308 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Klonopin |
| Generic Name | Clonazepam |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 1975-06-02 |
| Marketing Category | NDA / NDA |
| Application Number | NDA017533 |
| Labeler Name | Mckesson Rxpak Inc |
| Substance Name | CLONAZEPAM |
| Active Ingredient Strength | 1 mg/1 |
| Pharm Classes | Benzodiazepine [EPC],Benzodiazepines [CS] |
| DEA Schedule | CIV |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |
| Marketing Start Date | 2010-08-26 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA017533 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2002-11-19 |
| Marketing End Date | 2019-09-01 |
| Ingredient | Strength |
|---|---|
| CLONAZEPAM | .5 mg/1 |
| SPL SET ID: | 8d0621b0-353e-4c4d-86de-0d6f263bff4b |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0004-0058 | Klonopin | Clonazepam |
| 0004-0068 | Klonopin | Clonazepam |
| 0004-0098 | Klonopin | Clonazepam |
| 65084-308 | Klonopin | Klonopin |
| 65084-309 | Klonopin | Klonopin |
| 80425-0125 | Klonopin | Klonopin |
| 0093-0832 | Clonazepam | Clonazepam |
| 0093-0833 | Clonazepam | Clonazepam |
| 0093-0834 | Clonazepam | Clonazepam |
| 0093-3212 | Clonazepam | Clonazepam |
| 0093-3213 | Clonazepam | Clonazepam |
| 0093-9290 | Clonazepam | Clonazepam |
| 0093-9291 | Clonazepam | Clonazepam |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() KLONOPIN 75222722 2186702 Live/Registered |
Hoffmann-La Roche Inc. 1997-01-08 |
![]() KLONOPIN 73593338 1415564 Live/Registered |
HOFFMANN-LA ROCHE INC. 1986-04-14 |